• One-Stop CAR-T Therapy Development
  • Biomarker Identification & Selection
  • ScFv Generation
  • CAR Design & Construction
  • CAR-T Gene Packaging & Delivery
  • Replication-Competent Virus Testing
  • CAR Cell In Vitro Assay
  • CAR-T Preclinical In Vivo Assay
  • IND Development for CAR-T Cell Therapy
  • GMP Production for CAR-T Products
  • CAR Clinical Trial
  • One-Stop Canine CAR-T Therapy Development
  • One-Stop mRNA CAR-T Therapy Development
  • TRAC-CAR-T Cell Development
  • Modular CAR-T Cell Generation
  • One-Stop Silence™ CAR-T Cell Development
  • Vaccine Boosting CAR-T Cell Therapy
  • STAb-T Cell Therapy Development
  • CAR-T Therapy Development in the Non-Cancer Field
  • Anti-HIV CAR Cell Therapy Development
  • T Cell Activity Modulator Discovery
  • T Cell Programming
  • Virus Specific T Cell (VST) Development
  • Antibody-Coupled T Cell Receptor (ACTR) Development
  • Organoid-induced hPSC-original T Cell Differentiation
  • γδ T Cell Engineering
• One-Stop TCR-T Therapy Development
  • TCR Biomarker Identification & Selection
  • TCR Generation & Optimization
  • TCR Design & Construction
  • TCR Gene Packaging & Delivery
  • TCR In Vitro Assay
  • TCR-T Preclinical In Vivo Assay
  • TCR Clinical Application
  • TCR Analysis
  • TCR Tetramerization Construction
  • ScFv-TCR T Cell Therapy Development
  • AbTCR Development
  • Bispecific TCR Development
  • CER Development
• One-Stop CAR-MA Therapy Development
• One-Stop CAR-NK Therapy Development
  • One-Stop CAR-NKT Therapy Development
  • One-Stop UniCAR-NK Therapy Development
  • iPSC-derived CAR-NK Therapy Development
  • One-Stop TCR-NK Therapy Development
  • NK Cell Genetic Engineering
  • NK Cell Expansion
• One-Stop CAR-B Therapy Development
• One-Stop CAR-Monocyte Therapy Development
• One-Stop Cytokine Release Syndrome (CRS) Management
• TCR-Like Antibody Development
  • MHC/Peptide Complex Production
  • TCR-Like Antibody Discovery
  • TCR-Like Antibody Affinity Characterization
  • TCR-Like CAR Construction & Evaluation
• In Vivo Cell Engineering Development
  • In Vivo CAR-T Cell Engineering
  • In Vivo B Cell Engineering
  • In Vivo CAR-NK Cell Engineering
  • In Vivo CAR-M Cell Engineering
• One-Stop Allogeneic Cell Therapy Development
  • Allogeneic CAR-T Therapy Development
  • Allogeneic TCR-T Therapy Development
  • Allogeneic CAR-NK Therapy Development
  • Allogeneic CAR/TCR Cell Design & Engineering
  • Other Allogeneic Cell Therapy Development
• TCR/CAR/Antigen-Engineered Tregs Development
  • CAR-Treg Development
• Cancer Vaccine Development
  • Cancer Vaccine Discovery
  • Cancer Vaccine Engineering
  • Cancer Vaccine Analytical Characterization
  • Cancer Vaccine In Vivo Assessment
  • Cancer Vaccine GMP Manufacturing
  • Dendritic Cell Vaccine Development
• Immune Genotyping
  • HLA Typing
  • KIR Typing
  • HLA Testing
  • Dog DLA Genotyping
  • Guinea Pig GPLA Genotyping
  • Mouse H2 Genotyping
  • Rabbit RLA Genotyping
  • Rat RT1 Genotyping
  • Rhesus Macaque MHC Genotyping
• TIL Therapy Development
  • One-Stop TIL Development
  • Special TIL Therapy Development
• CIK Therapy Development
  • One-Stop CIK Therapy Development
  • CIK Therapy Improvement
• Artificial T Cell-Stimulating Platform Development
  • Artificial T Cell Stimulator Development
  • Hydrogel-based Artificial T Cell-Stimulating Platform Development
  • DNA-based Artificial T Cell-Stimulating Platform Development
  • Alternative Polymeric-based Artificial T Cell-Stimulating Platform Development
  • Soluble Artificial T Cell-Stimulating Platform Development
  • Artificial T Cell-Stimulating System Function Characterization
• Other Services
  • Tumor-infiltrating Lymphocyte-based Antibody Discovery

Creative Biolabs has a tradition of commitment. To achieve efficient execution and regulatory approval, we offer careful considerations of your program for the development of a cellular or gene therapy product – now and in the future.

• TCR-T Development Solutions
• CAR-T Development Solutions

• Process Development
• Analytical Development
• CAR-T Plasmid CDMO
  • RG CAR-T Plasmid DNA Manufacturing
  • GMP-like CAR-T Plasmid Manufacturing
  • GMP CAR-T Plasmid DNA Manufacturing
• CAR Viral Vector CDMO
  • RG CAR-T Virus Manufacturing
  • GMP-like CAR-T Virus Manufacturing
  • GMP CAR-T Virus Manufacturing
  • cGMP CAR-T AAV Production
  • cGMP CAR-T Lentivirus Production
  • cGMP CAR-T Retrovirus Production
  • Custom cGMP CAR-T Virus Production
• CAR IVT RNA & LNP Manufacturing
  • RG CAR-T mRNA Manufacturing
  • GMP-like CAR-T mRNA Manufacturing
  • GMP CAR-T mRNA Manufacturing
  • CAR-T Lipid Nanoparticle Encapsulation
• CAR Viral Vector Packaging
  • CAR-T AAV Packaging
  • CAR-T Lentivirus Packaging
• CAR Cell CDMO
  • IIT Grade CAR-T Manufacturing
  • IND Grade CAR-T Manufacturing
  • Clinical Grade CAR-T Manufacturing

The advent of Chimeric Antigen Receptor T-cell (CAR-T) therapies has revolutionized the field of oncology, providing new avenues for treating various forms of cancer. Our 20 years of experience in the biotechnology sector have equipped us with the expertise and technological capabilities to support the entire lifecycle of CAR-T products, from early development to commercialization.

• Support Knowledge
• Documents & Newsletters
• Webinars
• Podcasts
• Literature Reviews

Use the resources in our library to help you understand your options and make critical decisions for your study. We offer oncolytic virus, CAR-T, and dendritic cell related documents, as well as newsletter. If you don't find the answers you're looking for, contact us for additional assistance.

• Flyers
• Newsletter

• Distributors
• About Us
• Contact Us
• Careers
• Events

Get a real taste and understanding of the business and culture of one of the world's great research-based cellular and gene therapy discovery and development companies.